ADT Use and Duration With Definitive Radiotherapy for Localised Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Lancet Oncol 2022 Feb 01;23(2)304-316, AU Kishan, Y Sun, H Hartman, TM Pisansky, M Bolla, A Neven, A Steigler, JW Denham, FY Feng, A Zapatero, JG Armstrong, A Nabid, N Carrier, L Souhami, MT Dunne, JA Efstathiou, HM Sandler, A Guerrero, D Joseph, P Maingon, TM de Reijke, X Maldonado, TM Ma, T Romero, X Wang, MB Rettig, RE Reiter, NG Zaorsky, ML Steinberg, NG Nickols, AY Jia, JA Garcia, DE SprattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.